News

McGinley receives John S. Dunn Research Collaborative Award

04/22/2019

Dr, Matthew McGinely receives a seed grant to develop new brain technologies.

More

Tumor resection surgery curbed Hailey's seizures

07/18/2018

Hailey's story: Hope for Hailey

More

FDA approves everolimus for tuberous sclerosis-associated seizures, a treatment first discovered at Texas Children’s Hospital

04/20/2018

On April 10, 2018, the Food and Drug Administration (FDA) approved everolimus tablets for oral suspension (brand name: Afinitor Dispersz, Novartis Pharmaceuticals Corporation) as an adjunctive therapy to treat partial-onset refractory seizures in adults and children over 2 years of age with Tuber

More

Former British Prime Minister shares the lessons he learnt from his son's rare epileptic syndrome

03/02/2018

David Cameron’s son Ivan was born with a neurological disorder that baffled doctors. He was later diagnosed with Ohtahara syndromea, rare epileptic syndrome. Now, he writes, genomic testing can end the anguish of uncertainty.

More